美国食品药品监督管理局对暴露前预防用药持谨慎态度。 - Suppr

Suppr

超能文献

FDA treads carefully with PrEP.

作者信息

Holmes David

出版信息

Lancet Infect Dis. 2012 Jul;12(7):515-6. doi: 10.1016/s1473-3099(12)70160-3.

DOI:10.1016/s1473-3099(12)70160-3

PMID:22930826

Abstract

摘要

相似文献

FDA treads carefully with PrEP.

Lancet Infect Dis. 2012 Jul;12(7):515-6. doi: 10.1016/s1473-3099(12)70160-3.

A 4-drug combination (Stribild) for HIV.

Med Lett Drugs Ther. 2012 Nov 26;54(1404):95-6.

Preexposure chemoprophylaxis for HIV prevention.

N Engl J Med. 2011 Apr 7;364(14):1373; author reply 1374-5. doi: 10.1056/NEJMc1101504.

Preexposure prophylaxis for the prevention of HIV transmission to women.

AIDS. 2013 Jan 2;27(1):F1-5. doi: 10.1097/QAD.0b013e32835917b4.

Systemic preexposure prophylaxis for HIV: translating clinical data to clinical practice.

Ann Pharmacother. 2014 Apr;48(4):507-18. doi: 10.1177/1060028014520880. Epub 2014 Jan 28.

Study design considerations for evaluating efficacy of systemic preexposure prophylaxis interventions.

J Acquir Immune Defic Syndr. 2013 Jul;63 Suppl 2(0 2):S130-4. doi: 10.1097/QAI.0b013e3182986fac.

Oral preexposure anti-HIV prophylaxis for high-risk U.S. populations: current considerations in light of new findings.

AIDS Patient Care STDS. 2011 Feb;25(2):63-71. doi: 10.1089/apc.2010.0222.

Early experiences implementing pre-exposure prophylaxis (PrEP) for HIV prevention in San Francisco.

PLoS Med. 2014 Mar 4;11(3):e1001613. doi: 10.1371/journal.pmed.1001613. eCollection 2014 Mar.

Preexposure chemoprophylaxis for HIV prevention.

N Engl J Med. 2011 Apr 7;364(14):1373; author reply 1374-5. doi: 10.1056/NEJMc1101504.

When is good good enough for HIV-1 prophylaxis?

Lancet Infect Dis. 2014 Nov;14(11):1024-1025. doi: 10.1016/S1473-3099(14)70959-4. Epub 2014 Oct 7.

引用本文的文献

Lessons Learned in Centering Youth Voices in HIV Prevention: The Adolescent Health Working Group.

Prog Community Health Partnersh. 2022;16(4):551-561. doi: 10.1353/cpr.2022.0076.

Efficient single tobamoviral vector-based bioproduction of broadly neutralizing anti-HIV-1 monoclonal antibody VRC01 in Nicotiana benthamiana plants and utility of VRC01 in combination microbicides.

Antimicrob Agents Chemother. 2013 May;57(5):2076-86. doi: 10.1128/AAC.02588-12. Epub 2013 Feb 12.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

FDA treads carefully with PrEP.

Lancet Infect Dis. 2012 Jul;12(7):515-6. doi: 10.1016/s1473-3099(12)70160-3.

A 4-drug combination (Stribild) for HIV.

Med Lett Drugs Ther. 2012 Nov 26;54(1404):95-6.

Preexposure chemoprophylaxis for HIV prevention.

N Engl J Med. 2011 Apr 7;364(14):1373; author reply 1374-5. doi: 10.1056/NEJMc1101504.

Preexposure prophylaxis for the prevention of HIV transmission to women.

AIDS. 2013 Jan 2;27(1):F1-5. doi: 10.1097/QAD.0b013e32835917b4.

Systemic preexposure prophylaxis for HIV: translating clinical data to clinical practice.

Ann Pharmacother. 2014 Apr;48(4):507-18. doi: 10.1177/1060028014520880. Epub 2014 Jan 28.

Study design considerations for evaluating efficacy of systemic preexposure prophylaxis interventions.

J Acquir Immune Defic Syndr. 2013 Jul;63 Suppl 2(0 2):S130-4. doi: 10.1097/QAI.0b013e3182986fac.

Oral preexposure anti-HIV prophylaxis for high-risk U.S. populations: current considerations in light of new findings.

AIDS Patient Care STDS. 2011 Feb;25(2):63-71. doi: 10.1089/apc.2010.0222.

Early experiences implementing pre-exposure prophylaxis (PrEP) for HIV prevention in San Francisco.

PLoS Med. 2014 Mar 4;11(3):e1001613. doi: 10.1371/journal.pmed.1001613. eCollection 2014 Mar.

Preexposure chemoprophylaxis for HIV prevention.

N Engl J Med. 2011 Apr 7;364(14):1373; author reply 1374-5. doi: 10.1056/NEJMc1101504.

When is good good enough for HIV-1 prophylaxis?

Lancet Infect Dis. 2014 Nov;14(11):1024-1025. doi: 10.1016/S1473-3099(14)70959-4. Epub 2014 Oct 7.

引用本文的文献

Lessons Learned in Centering Youth Voices in HIV Prevention: The Adolescent Health Working Group.

Prog Community Health Partnersh. 2022;16(4):551-561. doi: 10.1353/cpr.2022.0076.

Efficient single tobamoviral vector-based bioproduction of broadly neutralizing anti-HIV-1 monoclonal antibody VRC01 in Nicotiana benthamiana plants and utility of VRC01 in combination microbicides.

Antimicrob Agents Chemother. 2013 May;57(5):2076-86. doi: 10.1128/AAC.02588-12. Epub 2013 Feb 12.